Sanger Genomics Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 17-12-2024
- Paid Up Capital ₹ 0.20 M
as on 17-12-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -52.66%
(FY 2020)
- Profit -100.34%
(FY 2020)
- Ebitda -90.88%
(FY 2020)
- Net Worth -0.37%
(FY 2020)
- Total Assets -0.74%
(FY 2020)
About Sanger Genomics
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Milind Doshi and Manisha Doshi serve as directors at the Company.
- CIN/LLPIN
U74120MH2015PTC265522
- Company No.
265522
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanger Genomics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milind Doshi  | Director | 13-Jun-2015 | Current |
| Manisha Doshi | Director | 13-Jun-2015 | Current |
Financial Performance of Sanger Genomics.
Sanger Genomics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 52.66% decrease. The company also saw a substantial fall in profitability, with a 100.34% decrease in profit. The company's net worth dipped by a decrease of 0.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanger Genomics?
In 2019, Sanger Genomics had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rapport Holding And Commercial Private LimitedActive 38 years 8 days
Milind Doshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanger Genomics?
Unlock and access historical data on people associated with Sanger Genomics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanger Genomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanger Genomics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
